Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Toxicology ; 472: 153179, 2022 04 30.
Artículo en Inglés | MEDLINE | ID: mdl-35429622

RESUMEN

Toxic effects of lead (Pb) are principally manifested in the central nervous system (CNS) and a mounting body of evidence indicates that excessive chronic exposure to Pb participates in the pathological processes of numerous neurodegenerative disorders in humans.In this study we evaluated whether the prolonged pre- and postnatal exposure of rat pups to lead, administrated through ingestion in drinking water, as a typical environmental exposure, can determine alterations of the protein pattern of CNS myelin and the induction of myelin-associated proteinases. Pregnant dams were given distilled water or 0.3 mg/mL lead acetate in drinking water during gestation and lactation. At postnatal day (PND) 21, pups born from mothers poisoned with Pb continued the treatment with the metal. On PND 35 and 56, pups were sacrificed, and brains were subjected to myelin purification and extraction of myelin-associated proteinases. The SDS-PAGE analysis of protein pattern of myelin incubated in vitro with an oxidative system indicated that myelin proteins from Pb-treated pups were more sensitive to the toxicity of reactive oxygen species in comparison with those from untreated pups. The zymografic analysis of NaCl-extracts from myelin of Pb-treated pups showed a band of digestion of 54 kDa that increased in pups sacrificed at PND 56 in comparison with those sacrificed at PND 35 and correlated with the concentration of Pb, detected in purified myelin. The incubation of the NaCl-extract from Pb-treated pups with purified myelin basic protein (MBP) evidenced the presence of different MBP-degrading activities. These results suggest that Pb may influence the integrity of the myelin sheath, probably through the induction of anti-myelin proteinases.


Asunto(s)
Agua Potable , Intoxicación del Sistema Nervioso por Plomo , Efectos Tardíos de la Exposición Prenatal , Animales , Animales Recién Nacidos , Femenino , Humanos , Plomo/toxicidad , Vaina de Mielina , Péptido Hidrolasas , Embarazo , Efectos Tardíos de la Exposición Prenatal/inducido químicamente , Ratas , Cloruro de Sodio/toxicidad
2.
Inflammopharmacology ; 29(2): 561-571, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33196947

RESUMEN

Isothiocyanates (ITCs), present as glucosinolate precursors in cruciferous vegetables, have shown anti-inflammatory, antioxidant and anticarcinogenic activities. Here, we compared the effects of three different ITCs on ROS production and on the expression of matrix metalloproteinase (MMP)-2 and -9, which represent important pathogenetic factors of various neurological diseases. Primary cultures of rat astrocytes were activated by LPS and simultaneously treated with different doses of Allyl isothiocyanate (AITC), 2-Phenethyl isothiocyanate (PEITC) and 2-Sulforaphane (SFN). Results showed that SFN and PEITC were able to counteract ROS production induced by H2O2. The zymographic analysis of cell culture supernatants evidenced that PEITC and SFN were the most effective inhibitors of MMP-9, whereas, only SFN significantly inhibited MMP-2 activity. PCR analysis showed that all the ITCs used significantly inhibited both MMP-2 and MMP-9 expression. The investigation on the mitogen-activated protein kinase (MAPK) signaling pathway demonstrated that ITCs modulate MMP transcription by inhibition of extracellular-regulated protein kinase (ERK) activity. Results of this study suggest that ITCs could be promising nutraceutical agents for the prevention and complementary treatment of neurological diseases associated with MMP involvement.


Asunto(s)
Isotiocianatos/farmacología , Fármacos Neuroprotectores/farmacología , Sulfóxidos/farmacología , Animales , Astrocitos/efectos de los fármacos , Astrocitos/patología , Células Cultivadas , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Femenino , Inflamación/tratamiento farmacológico , Inflamación/patología , Isotiocianatos/administración & dosificación , Masculino , Metaloproteinasa 2 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Fármacos Neuroprotectores/administración & dosificación , Ratas , Ratas Wistar , Especies Reactivas de Oxígeno/metabolismo , Sulfóxidos/administración & dosificación
3.
Sci Rep ; 9(1): 642, 2019 01 24.
Artículo en Inglés | MEDLINE | ID: mdl-30679613

RESUMEN

Compact myelin forms the basis of nerve insulation essential for higher vertebrates. Dozens of myelin membrane bilayers undergo tight stacking, and in the peripheral nervous system, this is partially enabled by myelin protein zero (P0). Consisting of an immunoglobulin (Ig)-like extracellular domain, a single transmembrane helix, and a cytoplasmic extension (P0ct), P0 harbours an important task in ensuring the integrity of compact myelin in the extracellular compartment, referred to as the intraperiod line. Several disease mutations resulting in peripheral neuropathies have been identified for P0, reflecting its physiological importance, but the arrangement of P0 within the myelin ultrastructure remains obscure. We performed a biophysical characterization of recombinant P0ct. P0ct contributes to the binding affinity between apposed cytoplasmic myelin membrane leaflets, which not only results in changes of the bilayer properties, but also potentially involves the arrangement of the Ig-like domains in a manner that stabilizes the intraperiod line. Transmission electron cryomicroscopy of native full-length P0 showed that P0 stacks lipid membranes by forming antiparallel dimers between the extracellular Ig-like domains. The zipper-like arrangement of the P0 extracellular domains between two membranes explains the double structure of the myelin intraperiod line. Our results contribute to the understanding of PNS myelin, the role of P0 therein, and the underlying molecular foundation of compact myelin stability in health and disease.


Asunto(s)
Membrana Celular/metabolismo , Proteína P0 de la Mielina/química , Proteína P0 de la Mielina/metabolismo , Humanos , Modelos Moleculares , Conformación Proteica
4.
J Neurochem ; 144(3): 271-284, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-29210076

RESUMEN

There is little information available on the possible toxic effects that antiretroviral (ARV) drugs used for the treatment of human immunodeficiency virus (HIV)-infected subjects, may have on the central nervous system (CNS) resident cells. Moreover, it remains unclear whether the efficacy of the ARV drugs may also be due to their ability to exert extravirological effects on factors responsible for the development of HIV brain injury, e.g., matrix metalloproteinases (MMPs). This study investigates the toxicity of three different ARV drugs and on their ability to modulate levels and expression of gelatinases A (MMP-2) and B (MMP-9) in astrocytes. Primary cultures of rat astrocytes were activated by exposure to lipopolysaccaride (LPS) and simultaneously treated with darunavir, maraviroc, or raltegravir, used alone or in combination. Among the tested drugs, maraviroc was the less toxic for astrocytes. At toxic concentration (TC50 ), the studied drugs induced the production of reactive oxygen species (ROS), suggesting that the oxidative stress may represent a mechanism of ARV toxicity. As assessed by gelatin zymography and RT-PCR, the single antiretroviral drugs reduced levels and expression of both MMP-2 and MMP-9 through the inhibition of the signaling transduction pathway of extracellular signal-regulated kinase1/2, which is involved in the regulation of MMP-9 gene. A synergistic inhibition of MMP-2 and MMP-9 was observed with combinations of the studied ARV drugs. The present results indicate that maraviroc, darunavir, and raltegravir, through their ability to inhibit MMP-2 and MMP-9 at doses non-toxic for astrocytes, might have a great potential for the management of HIV-associated neurological complications.


Asunto(s)
Antirretrovirales/toxicidad , Astrocitos/efectos de los fármacos , Astrocitos/metabolismo , Metaloproteinasa 2 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Animales , Supervivencia Celular , Darunavir/toxicidad , Femenino , Masculino , Maraviroc/toxicidad , Cultivo Primario de Células , Raltegravir Potásico/toxicidad , Ratas Wistar , Especies Reactivas de Oxígeno
5.
PLoS One ; 11(4): e0153451, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27097043

RESUMEN

Luminescent colloidal nanocrystals (NCs) are emerging as a new tool in neuroscience field, representing superior optical probes for cellular imaging and medical diagnosis of neurological disorders with respect to organic fluorophores. However, only a limited number of studies have, so far, explored NC applications in primary neurons, glia and related cells. Indeed astrocytes, as resident cells in the central nervous system (CNS), play an important pathogenic role in several neurodegenerative and neuroinflammatory diseases, therefore enhanced imaging tools for their thorough investigation are strongly amenable. Here, a comprehensive and systematic study on the in vitro toxicological effect of core-shell type luminescent CdSe@ZnS NCs incorporated in polyethylene glycol (PEG) terminated phospholipid micelles on primary cultures of rat astrocytes was carried out. Cytotoxicity response of empty micelles based on PEG modified phospholipids was compared to that of their NC containing counterpart, in order to investigate the effect on cell viability of both inorganic NCs and micelles protecting NC surface. Furthermore, since the surface charge and chemistry influence cell interaction and toxicity, effect of two different functional groups terminating PEG-modified phospholipid micelles, namely amine and carboxyl group, respectively, was evaluated against bare micelles, showing that carboxyl group was less toxic. The ability of PEG-lipid micelles to be internalized into the cells was qualitatively and quantitatively assessed by fluorescence microscopy and photoluminescence (PL) assay. The results of the experiments clearly demonstrate that, once incorporated into the micelles, a low, not toxic, concentration of NCs is sufficient to be distinctly detected within cells. The overall study provides essential indications to define the optimal experimental conditions to effectively and profitably use the proposed luminescent colloidal NCs as optical probe for future in vivo experiments.


Asunto(s)
Astrocitos/citología , Astrocitos/efectos de los fármacos , Micelas , Nanopartículas/química , Nanopartículas/toxicidad , Fosfolípidos/química , Animales , Astrocitos/metabolismo , Transporte Biológico , Compuestos de Cadmio/química , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Citotoxinas/química , Citotoxinas/metabolismo , Citotoxinas/toxicidad , Relación Dosis-Respuesta a Droga , Femenino , Sustancias Luminiscentes/química , Sustancias Luminiscentes/metabolismo , Sustancias Luminiscentes/toxicidad , Nanopartículas/metabolismo , Polietilenglicoles/química , Ratas , Ratas Wistar , Compuestos de Selenio/química , Sulfuros/química , Compuestos de Zinc/química
6.
PLoS One ; 10(6): e0129322, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26053757

RESUMEN

The aim of this study was to evaluate whether water soluble compounds present in aqueous extracts from seven Mediterranean demosponges exert biological activity towards matrix metalloproteinases (MMPs), which represent important pathogenic factors of human diseases. Aqueous extracts were tested on LPS-activated cultured rat astrocytes, and levels and expression of MMP-2 and MMP-9 were assessed by zymography and RT-PCR, respectively. Our results demonstrated that the studied extracts contain water soluble compounds able to inhibit MMP-2 and MMP-9 activity and expression. We also compared the anti-MMP activities present in aqueous extracts from wild and reared specimens of Tethya aurantium and T. citrina. The results obtained revealed that the reared sponges maintain the production of bioactive compounds with inhibitory effect on MMP-2 and MMP-9 for all the duration of the rearing period. Taken together, our results indicate that the aqueous extracts from the selected Mediterranean demosponges possess a variety of water-soluble bioactive compounds, which are able to inhibit MMPs at different levels. The presence of biological activity in aqueous extracts from reared specimens of T. aurantium and T. citrina strongly encourage sponge aquaculture as a valid option to supply sponge biomass for drug development on a large scale.


Asunto(s)
Astrocitos/enzimología , Mezclas Complejas/farmacología , Gelatinasas/genética , Metaloproteinasa 2 de la Matriz/genética , Metaloproteinasa 9 de la Matriz/genética , Inhibidores de la Metaloproteinasa de la Matriz/farmacología , Poríferos/química , Animales , Astrocitos/efectos de los fármacos , Muerte Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Lipopolisacáridos/farmacología , Metaloproteinasa 2 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Mar Mediterráneo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Agua de Mar , Agua
7.
Environ Toxicol Pharmacol ; 38(3): 1007-15, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25461562

RESUMEN

Marine natural products extracted from sponges represent a new source for drug discovery. Here we describe a simple method for preparing aqueous extracts from 7 Mediterranean demosponges, which allowed the extraction of water-soluble compounds, such as proteins by homogenization of sponge tissue in phosphate buffered saline (PBS). The comparative analysis by SDS-PAGE showed differences in number of bands, bandwidth and intensity among the sponges analyzed. The PAS/silver staining revealed a substantial and different glycoprotein assortment among the demosponges studied. To further study the biological activities present in the sponge extracts, we determined the non-cytotoxic doses on four different mammalian cell types demonstrating that the optimal non-cytotoxic doses were cell type- and extract-dependent. In conclusion, the extraction method described in this paper represents a fast and efficient procedure for the extraction of water-soluble proteins from marine sponges. Furthermore, the cell viability data suggest the feasibility of this method for the direct in vitro cell-based assays.


Asunto(s)
Astrocitos/efectos de los fármacos , Electroforesis en Gel de Poliacrilamida/métodos , Poríferos/química , Proteínas/análisis , Animales , Productos Biológicos/análisis , Productos Biológicos/farmacología , Células CACO-2 , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Cricetinae , Glicoproteínas/análisis , Humanos , Dosis Máxima Tolerada , Poríferos/clasificación , Proteínas/farmacología , Ratas , Solubilidad
8.
Toxicol Sci ; 135(1): 218-28, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23811825

RESUMEN

Manganese (Mn) is an environmental contaminant and its overexposure contributes to the pathophysiological processes of numerous disorders of the central nervous system in humans with mechanisms of action not completely understood. Activation of astrocytes and the subsequent release of neurotoxic factors have been implicated to contribute to neurodegeneration. Here, we assessed the molecular basis of the effects of Mn on modulation of matrix metalloproteinases-2 (MMP-2) and -9 (MMP-9) in rat astrocyte cultures. Primary cultures of rat astrocytes were exposed to different doses of MnCl2. Culture supernatants and cell lysates were used for the detection of MMP-2 and MMP-9 levels and mRNA expression, respectively. The exposure of astrocytes to MnCl2 induced the levels and expression of MMP-9 in a dose-dependent manner. The addition of resveratrol (RSV) inhibited both levels and expression of MMP-9 in astrocytes, whereas N-acetylcysteine (NAC) and quercetin (QRC) were ineffective in inhibiting MMP-9. As a possible mechanism of Mn-induced MMP-9, we determined intracellular redox state in Mn-treated astrocytes by assessing superoxide dismutase (SOD) activity and intracellular reactive oxygen species (ROS) and found a significant increase of ROS and a decrease of SOD activity. RSV, NAC, and QRC restored the redox state. The study of the mitogen-activated protein kinase signaling pathway demonstrated that MMP-9 transcription is mainly regulated by extracellular-regulated protein kinases (ERK). Pretreatment with RSV significantly reduced ERK activation suggesting that its ability to counteract MMP-9 overexpression is due not only to a general redox balance phenomenon but also to the modulation of ERK signaling pathway.


Asunto(s)
Astrocitos/efectos de los fármacos , Enfermedades del Sistema Nervioso Central/tratamiento farmacológico , Manganeso/toxicidad , Metaloproteinasa 9 de la Matriz/biosíntesis , Estilbenos/farmacología , Superóxido Dismutasa/metabolismo , Acetilcisteína/farmacología , Animales , Astrocitos/enzimología , Células Cultivadas , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Metaloproteinasa 9 de la Matriz/análisis , Quercetina/farmacología , Ratas , Especies Reactivas de Oxígeno/metabolismo , Resveratrol , Estilbenos/uso terapéutico
9.
PLoS One ; 8(2): e49656, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23390485

RESUMEN

BACKGROUND: Proteolytic enzymes have been implicated in the pathogenesis of Multiple Sclerosis (MS) for both their ability to degrade myelin proteins and for their presence in MS plaques.In this study we investigated whether interferon-beta (IFN-ß) could differently modulate the activity and the expression of proteolytic activities against myelin basic protein (MBP) present in lipopolysaccharide (LPS)-activated astrocytes. METHODOLOGY/PRINCIPAL FINDINGS: Rat astrocyte cultures were activated with LPS and simultaneously treated with different doses of IFN-ß. To assess the presence of MBP-cleaving proteolytic activity, culture supernatants and cellular extracts collected from astrocytes were incubated with exogenous MBP. A MBP-degrading activity was found in both lysates and supernatants from LPS-activated astrocytes and was dose-dependently inhibited by IFN-ß. The use of protease inhibitors as well as the zymographic analysis indicated the presence of calpain II (CANP-2) in cell lysates and gelatinases A (MMP-2) and B (MMP-9) in cell supernatants. RT-PCR revealed that the expression of CANP-2 as well as of MMP-2 and MMP-9 was increased in LPS-activated astrocytes and was dose-dependently inhibited by IFN-ß treatment. The expression of calpastatin, the natural inhibitor of CANPs, was not affected by IFN-ß treatment. By contrast, decreased expression of TIMP-1 and TIMP-2, the natural inhibitors of MMP-9 and MMP-2, respectively, was observed in IFN-ß-treated astrocytes compared to LPS-treated cells. The ratio enzyme/inhibitor indicated that the effect of IFN-ß treatment is more relevant to CANP-2 than on MMPs. CONCLUSIONS/ SIGNIFICANCE: These results suggest that the neuroinflammatory damage during MS involves altered balance between multiple proteases and their inhibitors and indicate that IFN-ß is effective in regulating different enzymatic systems involved in MS pathogenesis.


Asunto(s)
Astrocitos/efectos de los fármacos , Calpaína/metabolismo , Interferón beta/farmacología , Metaloproteinasa 2 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Proteína Básica de Mielina/metabolismo , Vaina de Mielina/metabolismo , Animales , Astrocitos/citología , Astrocitos/metabolismo , Proteínas de Unión al Calcio/genética , Proteínas de Unión al Calcio/metabolismo , Calpaína/antagonistas & inhibidores , Calpaína/genética , Citosol/efectos de los fármacos , Citosol/metabolismo , Relación Dosis-Respuesta a Droga , Espacio Extracelular/efectos de los fármacos , Espacio Extracelular/metabolismo , Expresión Génica/efectos de los fármacos , Lipopolisacáridos/farmacología , Metaloproteinasa 2 de la Matriz/genética , Metaloproteinasa 9 de la Matriz/genética , Proteína Básica de Mielina/genética , Vaina de Mielina/efectos de los fármacos , Cultivo Primario de Células , Inhibidores de Proteasas/farmacología , Ratas , Inhibidor Tisular de Metaloproteinasa-1/antagonistas & inhibidores , Inhibidor Tisular de Metaloproteinasa-1/genética , Inhibidor Tisular de Metaloproteinasa-1/metabolismo , Inhibidor Tisular de Metaloproteinasa-2/antagonistas & inhibidores , Inhibidor Tisular de Metaloproteinasa-2/genética , Inhibidor Tisular de Metaloproteinasa-2/metabolismo
10.
Mol Pharm ; 6(5): 1363-70, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19281192

RESUMEN

The binding selectivity of charged liposomes to the spinal cord of rats affected by experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis, was investigated. Positively and negatively charged liposomes were injected into the tail vein of rats, and blood/brain barrier (BBB) targeting was determined by confocal microscopy as a function of the temporal evolution of the inflammatory response. Accumulation in spinal cord endoneural vessels was observed for cationic, but not for anionic, liposomes, and only in EAE but not in healthy rats. The overall binding efficacy paralleled the severity of the clinical score, but targeting was observed already before clinical manifestation of inflammation. Preferential binding of positively charged liposomes in the course of acute EAE can be ascribed to subtle changes of BBB morphology and charge distribution in a similar way as for the binding of cationic particles to proliferating vasculature in chronic inflammation and angiogenesis. Our findings suggest that vascular changes related to increased binding affinity for cationic particles are very early events within the inflammatory reaction in acute EAE. Investigation of cationic vascular targeting can help to shed further light on these occurrences, and, potentially, new diagnostic and therapeutic options may become available. In neuroinflammatory diseases, cationic colloidal carrier particles may enable intervention at affected BBB by an approach which is independent from permeability increase.


Asunto(s)
Portadores de Fármacos/química , Encefalomielitis Autoinmune Experimental/tratamiento farmacológico , Liposomas/química , Animales , Barrera Hematoencefálica , Portadores de Fármacos/administración & dosificación , Encefalomielitis Autoinmune Experimental/metabolismo , Femenino , Liposomas/administración & dosificación , Microscopía Confocal , Neovascularización Patológica , Ratas , Ratas Endogámicas Lew , Médula Espinal/irrigación sanguínea , Médula Espinal/efectos de los fármacos , Médula Espinal/metabolismo , Electricidad Estática
11.
J Neurochem ; 107(1): 291-301, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18680558

RESUMEN

It is now well established that plasma membranes, such as the myelin sheath, are made of different microdomains with different lipid and protein composition. Lipid rafts are made mainly of sphingolipids and cholesterol, whereas the non-raft regions are made mainly of phosphoglycerides. Most myelin proteins may distribute themselves in raft and non-raft microdomains but the driving force that gives rise to their different distribution is not known yet. In this paper, we have studied the distribution of protein zero (P0), the most representative protein of PNS myelin, in the membrane microdomains. To this end, we have purified P0 from both non-raft (soluble P0, P0-S) and raft (P0-R) regions of PNS. Purified proteins were analyzed by two-dimensional gel electrophoresis and identified and characterized by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. A detailed structural description of the two P0 forms is given in terms of amino acid sequence, post-translational modifications, and composition of associated lipids. Our findings suggest that structural differences between the two proteins, mainly related to the glycogroups, might be responsible for their different localization.


Asunto(s)
Microdominios de Membrana/metabolismo , Proteína P0 de la Mielina/metabolismo , Vaina de Mielina/metabolismo , Fibras Nerviosas Mielínicas/metabolismo , Nervios Periféricos/metabolismo , Secuencia de Aminoácidos/fisiología , Animales , Bovinos , Femenino , Glicosilación , Proteína P0 de la Mielina/análisis , Proteína P0 de la Mielina/química , Vaina de Mielina/ultraestructura , Fibras Nerviosas Mielínicas/ultraestructura , Nervios Periféricos/ultraestructura , Isoformas de Proteínas/análisis , Isoformas de Proteínas/química , Isoformas de Proteínas/metabolismo , Procesamiento Proteico-Postraduccional/fisiología
12.
Neurochem Res ; 32(12): 2184-93, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17624613

RESUMEN

We investigated whether polyunsaturated fatty acids (PUFA), which might be a useful complementary therapy among patients with multiple sclerosis (MS), are able to modulate matrix metalloproteinase (MMP) production in microglial cultures. MMPs are myelinotoxic factors. Primary cultures of rat microglia were treated with different doses of omega-3 (omega-3) PUFA or purified fish oil, containing a mixture of omega-3 and omega-6 PUFA, and simultaneously activated by exposure to lipopolysaccharide (LPS). Culture supernatants were subjected to zymography and Western blot analysis for the assessment of MMP-2 and MMP-9 levels. Increased amounts of MMP-9, but not of the constitutively expressed MMP-2, were observed in supernatants from LPS-treated microglia in comparison with non-treated control cells. The treatment with both omega-3 PUFA and fish oil dose-dependently inhibited the LPS-induced production of MMP-9. Our results suggest that a low fat diet supplemented with omega-3 PUFA may become recommended for the well being of MS patients under therapy.


Asunto(s)
Terapias Complementarias , Ácidos Grasos Insaturados/farmacología , Metaloproteinasa 9 de la Matriz/metabolismo , Inhibidores de la Metaloproteinasa de la Matriz , Microglía/enzimología , Esclerosis Múltiple/tratamiento farmacológico , Animales , Animales Recién Nacidos , Western Blotting , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Ácidos Grasos Omega-3/farmacología , Gelatinasas/metabolismo , Interferón Tipo I/farmacología , Lipopolisacáridos/farmacología , Microglía/efectos de los fármacos , Ratas , Proteínas Recombinantes , Estimulación Química
13.
J Struct Biol ; 153(3): 253-63, 2006 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-16427315

RESUMEN

The P2 protein is a small, extrinsic protein of the myelin membrane in the peripheral nervous system that structurally belongs to the fatty acid binding proteins (FABPs) family, sharing with them a 10 strands beta-barrel structure. FABPs appear to be involved in cellular fatty acid transport, but very little is known about the role of P2 in the metabolism of peripheral myelin lipids. Study of protein conformation at different pHs is a useful tool for the characterization of the unfolding mechanisms and the intrinsic conformational properties of the protein, and may give insight into factors that guide protein folding pathways. In particular, low pH conditions have been shown to induce partially folded states in several proteins. In this paper, the acidic unfolding of purified P2 protein was studied with both spectroscopic techniques and molecular dynamics simulation. Both experimental and computational results indicate the presence of a partly folded state at low pH, which shows structural changes mainly involving the lid that is formed by the helix-turn-helix domain. The opening of the lid, together with a barrel relaxation, could regulate the ligand exchanges near the cell membrane, supporting the hypothesis that the P2 protein may transport fatty acids between Schwann cells and peripheral myelin.


Asunto(s)
Biología Computacional , Proteína P2 de Mielina/química , Animales , Concentración de Iones de Hidrógeno , Conformación Proteica , Pliegue de Proteína
14.
Mult Scler ; 10(3): 290-7, 2004 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-15222694

RESUMEN

Matrix metalloproteinases (MMPs) have been identified as mediators of brain injury in multiple sclerosis (MS) and it has recently been reported that treatment of MS patients with interferon-beta (IFN-beta) reduces MMP-9 serum levels and in vitro release from monocytes. We investigated whether IFN-beta is able to modulate the expression of MMPs in glial cell cultures. Rat microglial and astrocyte cultures were treated with different doses of IFN-beta, then activated by exposure to LPS. In another set of experiments cells were simultaneously activated with LPS and treated with IFN-beta. Culture supernatants collected from astrocytes and microglia were subjected to zymography for the assessment of MMP-2 and MMP-9. Increased amounts of MMP-9 and MMP-2 were observed in supernatants from LPS-treated astrocytes in comparison with supernatants from nontreated control cells. MMP-9 also increased in LPS-treated microglia. The treatment of astrocytes and microglia with IFN-beta inhibited dose-dependently the expression of both MMP-2 and MMP-9 in LPS-treated astrocytes and of MMP-9 in LPS-treated microglia. These results demonstrate a modulating effect of IFN-beta on the release of MMPs from CNS cells. This effect represents an additional mechanism by which IFN-beta, may decrease the development of new CNS lesions in the course of MS.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Interferón beta/farmacología , Metaloproteinasa 2 de la Matriz/metabolismo , Metaloproteinasa 9 de la Matriz/metabolismo , Microglía/efectos de los fármacos , Esclerosis Múltiple/tratamiento farmacológico , Animales , Astrocitos/citología , Astrocitos/efectos de los fármacos , Astrocitos/enzimología , Células Cultivadas , Medios de Cultivo/metabolismo , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Metaloproteinasa 2 de la Matriz/genética , Metaloproteinasa 9 de la Matriz/genética , Microglía/citología , Microglía/enzimología , Esclerosis Múltiple/etiología , Esclerosis Múltiple/inmunología , ARN Mensajero/análisis , Ratas
15.
J Struct Biol ; 142(2): 292-300, 2003 May.
Artículo en Inglés | MEDLINE | ID: mdl-12713957

RESUMEN

The P2 protein of peripheral nervous system myelin induces experimental allergic neuritis in rats, a model of Guillain-Barré syndrome in humans. Previous purification procedures have used acid extraction to obtain the protein in lipid-free form (LF-P2). Here, we have purified the P2 protein in lipid-bound form (LB-P2) by extracting myelin with the detergent CHAPS, followed by Cu(2+)-affinity column chromatography. All myelin lipids were present in the preparation as shown by high-performance thin-layer chromatography and mass spectrometry. The LB-P2 preparation, which differs from LF-P2 in solubility and in the secondary-structure composition, was dialyzed to remove unbound lipids and excess detergent and crystallized using the hanging-drop vapor diffusion technique. Crystals of lipid-bound P2 appeared usually very reproducibly within 2 weeks at pH 5.7 in polyethylene glycol 6000 (PEG6000) at concentrations of 20-30% (w/v), and larger crystals were obtained by additional sitting-drop crystallization. X-ray diffraction showed reflections up to 2.7A. The crystallization conditions (25-30% PEG6000, pH 5.0) and the unit cell dimensions (a = 94.5A, b = 94.5A, c=74.2A, alpha = beta = 90 degrees, gamma = 120 degrees ) of LB-P2 were different from those earlier described for LF-P2 (10% PEG4000, pH 3, and unit cell dimensions a = 91.8A, b = 99.5A, c = 56.5A, alpha = beta = gamma = 90.0 degrees ). It is important that P2 has been crystallized with specifically bound lipids; therefore, solving this new crystal structure will reveal details of this protein's behavior and role in the myelin sheath.


Asunto(s)
Cristalización/métodos , Lípidos/química , Proteína P2 de Mielina/química , Animales , Cristalografía por Rayos X , Histidina , Lípidos/aislamiento & purificación , Microdominios de Membrana/química , Proteínas de la Membrana/química , Proteína P2 de Mielina/aislamiento & purificación , Unión Proteica , Espectrometría de Masa por Ionización de Electrospray , Raíces Nerviosas Espinales/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...